IBHRE CCDS PRACTICE EXAM – QUESTIONS AND ANSWERS |
VERIFIED AND WELL DETAILED ANSWERS | PLUS RATIONALES
| GUARANTEED PASS | LATEST EXAM UPDATE
Core Domains:
1. Cardiac Anatomy and Physiology
2. Electrophysiology and Arrhythmia Mechanisms
3. Device Indications and Patient Selection
4. Pacemaker and ICD Function and Programming
5. Device Implantation Procedures and Techniques
6. Follow-up and Remote Monitoring
7. Troubleshooting and Managing Device Complications
8. Regulatory Compliance, Ethics, and Professional Standards
9. Hemodynamics and Pharmacology
10. Special Populations and Clinical Decision-Making
Introduction
This comprehensive examination is designed to assess the knowledge, clinical judgment, and decision-
making skills essential for the International Board of Heart Rhythm Examiners (IBHRE) Certified
Cardiac Device Specialist (CCDS) credential. The exam evaluates foundational theory, applied
professional knowledge, regulatory and legal compliance, and ethical standards within the field of
cardiac rhythm device management. Candidates will encounter multiple-choice questions and
scenario-based items that reflect real-world clinical situations, requiring critical thinking and the
application of evidence-based practices. This practice assessment aims to prepare candidates by
simulating the structure, content, and rigor of the actual certification examination, emphasizing safe,
effective, and patient-centered care in cardiac electrophysiology.
SECTION ONE: QUESTIONS 1–100
Question 1
What is the primary mechanism by which the sinoatrial (SA) node initiates an action potential?
A. Rapid influx of sodium ions through fast channels
B. Slow influx of calcium ions through L-type channels
,C. Influx of potassium ions through inward rectifier channels
D. Efflux of chloride ions through anion channels
🟢B
🔴 Explanation: The SA node is a slow-response tissue that relies on the slow inward calcium
current (I Ca-L) through L-type calcium channels for its upstroke. This differs from fast-response
tissues like atrial and ventricular muscle, which depend on rapid sodium influx.
Question 2
A patient with a dual-chamber pacemaker presents with a paced ventricular rate of 85 bpm, which
is above the programmed lower rate of 60 bpm. The atrial lead is functioning normally. What is the
most likely cause of this finding?
A. Sensor-driven rate response
B. Lead fracture
C. Battery depletion
D. Oversensing of myopotentials
🟢A
🔴 Explanation: Rate-responsive pacing uses sensors (e.g., accelerometer, minute ventilation) to
increase the pacing rate in response to physiologic demand. The atrial lead functioning normally
and a rate higher than the programmed lower rate suggests appropriate sensor-driven rate
response, not a device malfunction.
Question 3
Which of the following is the correct indication for placement of an implantable cardioverter-
defibrillator (ICD) in a patient with ischemic cardiomyopathy and a left ventricular ejection fraction
(LVEF) of 30%?
A. NYHA Class I symptoms only
B. NYHA Class II or III symptoms on optimal medical therapy
C. Presence of non-sustained ventricular tachycardia
D. Acute myocardial infarction within the past 48 hours
🟢B
🔴 Explanation: The MADIT-II and SCD-HeFT trials established ICD therapy for primary prevention
in patients with ischemic cardiomyopathy, LVEF ≤35%, and NYHA Class II or III symptoms on
optimal medical therapy. ICDs are not indicated immediately after MI (<40 days) or in NYHA Class I
alone without additional risk factors.
Question 4
,During device interrogation, the pacing threshold for the ventricular lead has increased from 0.8 V
at implant to 2.5 V at the 3-month follow-up. The capture morphology appears normal. What is the
most appropriate initial management step?
A. Schedule lead revision surgery
B. Increase the ventricular pacing output to a safe margin above threshold
C. Reduce the ventricular pacing output to preserve battery life
D. Prescribe antiarrhythmic medication to reduce pacing dependency
🟢B
🔴 Explanation: A gradual increase in pacing threshold is expected during the first weeks to
months post-implant due to local inflammatory and fibrotic tissue response at the lead tip. The
appropriate management is to reprogram the device output to ensure an adequate safety margin
(typically 2-3 times the threshold or ≥1.5 V) while continuing to monitor trends.
Question 5
What is the intrinsic rate of the atrioventricular (AV) junction if there is complete heart block and no
escape pacemaker is present?
A. 60-100 bpm
B. 40-60 bpm
C. 20-40 bpm
D. 0 bpm
🟢C
🔴 Explanation: The AV junction has an intrinsic escape rate of 40-60 bpm; however, if complete
heart block is present and there is no escape pacemaker functioning, the ventricular rate will default
to the next level of automaticity, which is the Purkinje system at 20-40 bpm. If no escape is present,
asystole occurs.
Question 6
A patient with a CRT-D device reports discomfort and muscle twitching in the left pectoral region
during pacing. What is the most likely cause?
A. Phrenic nerve stimulation
B. Lead dislodgement
C. Pacemaker syndrome
D. Myocardial perforation
🟢A
🔴 Explanation: Phrenic nerve stimulation is a known complication of left ventricular (LV) lead
placement in CRT systems. It occurs when the pacing stimulus activates the phrenic nerve, which
, runs near the epicardial surface. Discomfort and twitching are hallmark symptoms. Management
may involve reprogramming pacing output or vector, or lead repositioning.
Question 7
Which ion channel is primarily responsible for the rapid phase 3 repolarization of the cardiac action
potential?
A. Sodium channels
B. L-type calcium channels
C. Delayed rectifier potassium channels (I Kr)
D. Inward rectifier potassium channels (I K1)
🟢C
🔴 Explanation: Phase 3 repolarization is driven by the rapid component of the delayed rectifier
potassium current (I Kr) and the slow component (I Ks). These currents facilitate the efflux of
potassium ions, restoring the negative resting membrane potential. I K1 is important for
maintaining the resting potential but not the primary driver of phase 3.
Question 8
A patient with a single-chamber ventricular pacemaker has pacing spikes that appear on the ECG at
a rate of 40 bpm, despite a programmed lower rate of 60 bpm. Device interrogation reveals normal
battery voltage. What is the most likely explanation?
A. The pacemaker has entered the elective replacement interval (ERI)
B. The patient is experiencing pacemaker-mediated tachycardia
C. The device is in a sleep mode due to magnet application
D. The lead impedance is extremely low
🟢A
🔴 Explanation: When a pacemaker reaches the ERI, it typically reduces the base pacing rate (often
to 80% or a fixed rate like 40-50 bpm) to conserve remaining battery energy. Normal battery
voltage initially does not rule this out, as voltage may still appear normal but battery depletion has
progressed to the ERI threshold.
Question 9
What is the primary purpose of the blanking period in a cardiac device?
A. To prevent sensing of far-field signals
B. To allow for complete myocardial repolarization
C. To prevent the device from sensing its own paced events
D. To optimize AV delay for hemodynamic performance
VERIFIED AND WELL DETAILED ANSWERS | PLUS RATIONALES
| GUARANTEED PASS | LATEST EXAM UPDATE
Core Domains:
1. Cardiac Anatomy and Physiology
2. Electrophysiology and Arrhythmia Mechanisms
3. Device Indications and Patient Selection
4. Pacemaker and ICD Function and Programming
5. Device Implantation Procedures and Techniques
6. Follow-up and Remote Monitoring
7. Troubleshooting and Managing Device Complications
8. Regulatory Compliance, Ethics, and Professional Standards
9. Hemodynamics and Pharmacology
10. Special Populations and Clinical Decision-Making
Introduction
This comprehensive examination is designed to assess the knowledge, clinical judgment, and decision-
making skills essential for the International Board of Heart Rhythm Examiners (IBHRE) Certified
Cardiac Device Specialist (CCDS) credential. The exam evaluates foundational theory, applied
professional knowledge, regulatory and legal compliance, and ethical standards within the field of
cardiac rhythm device management. Candidates will encounter multiple-choice questions and
scenario-based items that reflect real-world clinical situations, requiring critical thinking and the
application of evidence-based practices. This practice assessment aims to prepare candidates by
simulating the structure, content, and rigor of the actual certification examination, emphasizing safe,
effective, and patient-centered care in cardiac electrophysiology.
SECTION ONE: QUESTIONS 1–100
Question 1
What is the primary mechanism by which the sinoatrial (SA) node initiates an action potential?
A. Rapid influx of sodium ions through fast channels
B. Slow influx of calcium ions through L-type channels
,C. Influx of potassium ions through inward rectifier channels
D. Efflux of chloride ions through anion channels
🟢B
🔴 Explanation: The SA node is a slow-response tissue that relies on the slow inward calcium
current (I Ca-L) through L-type calcium channels for its upstroke. This differs from fast-response
tissues like atrial and ventricular muscle, which depend on rapid sodium influx.
Question 2
A patient with a dual-chamber pacemaker presents with a paced ventricular rate of 85 bpm, which
is above the programmed lower rate of 60 bpm. The atrial lead is functioning normally. What is the
most likely cause of this finding?
A. Sensor-driven rate response
B. Lead fracture
C. Battery depletion
D. Oversensing of myopotentials
🟢A
🔴 Explanation: Rate-responsive pacing uses sensors (e.g., accelerometer, minute ventilation) to
increase the pacing rate in response to physiologic demand. The atrial lead functioning normally
and a rate higher than the programmed lower rate suggests appropriate sensor-driven rate
response, not a device malfunction.
Question 3
Which of the following is the correct indication for placement of an implantable cardioverter-
defibrillator (ICD) in a patient with ischemic cardiomyopathy and a left ventricular ejection fraction
(LVEF) of 30%?
A. NYHA Class I symptoms only
B. NYHA Class II or III symptoms on optimal medical therapy
C. Presence of non-sustained ventricular tachycardia
D. Acute myocardial infarction within the past 48 hours
🟢B
🔴 Explanation: The MADIT-II and SCD-HeFT trials established ICD therapy for primary prevention
in patients with ischemic cardiomyopathy, LVEF ≤35%, and NYHA Class II or III symptoms on
optimal medical therapy. ICDs are not indicated immediately after MI (<40 days) or in NYHA Class I
alone without additional risk factors.
Question 4
,During device interrogation, the pacing threshold for the ventricular lead has increased from 0.8 V
at implant to 2.5 V at the 3-month follow-up. The capture morphology appears normal. What is the
most appropriate initial management step?
A. Schedule lead revision surgery
B. Increase the ventricular pacing output to a safe margin above threshold
C. Reduce the ventricular pacing output to preserve battery life
D. Prescribe antiarrhythmic medication to reduce pacing dependency
🟢B
🔴 Explanation: A gradual increase in pacing threshold is expected during the first weeks to
months post-implant due to local inflammatory and fibrotic tissue response at the lead tip. The
appropriate management is to reprogram the device output to ensure an adequate safety margin
(typically 2-3 times the threshold or ≥1.5 V) while continuing to monitor trends.
Question 5
What is the intrinsic rate of the atrioventricular (AV) junction if there is complete heart block and no
escape pacemaker is present?
A. 60-100 bpm
B. 40-60 bpm
C. 20-40 bpm
D. 0 bpm
🟢C
🔴 Explanation: The AV junction has an intrinsic escape rate of 40-60 bpm; however, if complete
heart block is present and there is no escape pacemaker functioning, the ventricular rate will default
to the next level of automaticity, which is the Purkinje system at 20-40 bpm. If no escape is present,
asystole occurs.
Question 6
A patient with a CRT-D device reports discomfort and muscle twitching in the left pectoral region
during pacing. What is the most likely cause?
A. Phrenic nerve stimulation
B. Lead dislodgement
C. Pacemaker syndrome
D. Myocardial perforation
🟢A
🔴 Explanation: Phrenic nerve stimulation is a known complication of left ventricular (LV) lead
placement in CRT systems. It occurs when the pacing stimulus activates the phrenic nerve, which
, runs near the epicardial surface. Discomfort and twitching are hallmark symptoms. Management
may involve reprogramming pacing output or vector, or lead repositioning.
Question 7
Which ion channel is primarily responsible for the rapid phase 3 repolarization of the cardiac action
potential?
A. Sodium channels
B. L-type calcium channels
C. Delayed rectifier potassium channels (I Kr)
D. Inward rectifier potassium channels (I K1)
🟢C
🔴 Explanation: Phase 3 repolarization is driven by the rapid component of the delayed rectifier
potassium current (I Kr) and the slow component (I Ks). These currents facilitate the efflux of
potassium ions, restoring the negative resting membrane potential. I K1 is important for
maintaining the resting potential but not the primary driver of phase 3.
Question 8
A patient with a single-chamber ventricular pacemaker has pacing spikes that appear on the ECG at
a rate of 40 bpm, despite a programmed lower rate of 60 bpm. Device interrogation reveals normal
battery voltage. What is the most likely explanation?
A. The pacemaker has entered the elective replacement interval (ERI)
B. The patient is experiencing pacemaker-mediated tachycardia
C. The device is in a sleep mode due to magnet application
D. The lead impedance is extremely low
🟢A
🔴 Explanation: When a pacemaker reaches the ERI, it typically reduces the base pacing rate (often
to 80% or a fixed rate like 40-50 bpm) to conserve remaining battery energy. Normal battery
voltage initially does not rule this out, as voltage may still appear normal but battery depletion has
progressed to the ERI threshold.
Question 9
What is the primary purpose of the blanking period in a cardiac device?
A. To prevent sensing of far-field signals
B. To allow for complete myocardial repolarization
C. To prevent the device from sensing its own paced events
D. To optimize AV delay for hemodynamic performance
